Skip to main content
European Commission logo
English English
CORDIS - EU research results
CORDIS

EARLY DYNAMIC SCREENING FOR COLORECTAL CANCER VIA NOVEL PROTEIN BIOMARKERS REFLECTING BIOLOGICAL INITIATION MECHANISMS

Project description

Innovative risk assessment and screening method for colorectal cancer

The EU-funded DIOPTRA project aims to introduce a front-line screening tool that will consider risk factors and protein biomarkers for pinpointing individuals at a high risk for developing colorectal cancer (CRC). Tissue and blood samples will be examined for a discriminative set of prognostic proteins that are detectable via standard blood work and can indicate a need for further evaluation (i.e. colonoscopy). Other data (e.g. medical, behavioural) will also be considered as potential risk factors. AI will be leveraged for assessing prognostic power, while personalised behavioural changes will be promoted based on modifiable risk factors. Given the low citizen participation in CRC screening across the EU, DIOPTRA seeks to broaden the evaluated population, boosting participation rates and bypassing age screening thresholds.

Objective

DIOPTRA aims to introduce a front-line screening tool that will consider risk factors and protein biomarkers for pinpointing individuals at a high risk for colorectal cancer (CRC) incidence. Tissue & blood samples will be examined towards a discriminative set of prognostic proteins that are detectable via standard bloodwork and can indicate a need for further evaluation (i.e. colonoscopy). Other data (e.g. medical, behavioural) will also be considered as potential risk factors. Artificial intelligence (AI) will be leveraged for assessing prognostic power, while personalised behavioural change will be promoted based on modifiable risk factors. Given the low citizen participation on CRC screening across EU, DIOPTRA seeks to broaden the evaluated population, boosting participation rates and bypassing age screening thresholds. This action is part of the Cancer Mission cluster of projects on ‘Prevention, including Screening’.

Programme(s)

Coordinator

EREVNITIKO PANEPISTIMIAKO INSTITOUTO SYSTIMATON EPIKOINONION KAI YPOLOGISTON
Net EU contribution
€ 942 500,00
Address
PATISION 42
106 82 ATHINA
Greece

See on map

Region
Αττική Aττική Κεντρικός Τομέας Αθηνών
Activity type
Research Organisations
Links
Total cost
€ 942 500,00

Participants (25)

Partners (3)